These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9748879)

  • 1. [Needle-like inclusions in liver cells are specific diagnostic signs of porphyria cutanea tarda].
    Fakan F; Chlumská A; Malina L
    Vnitr Lek; 1998 Jul; 44(7):418-22. PubMed ID: 9748879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic liver cell inclusions--a typical feature of porphyria cutanea tarda--are absent in porphyria-related hepatic neoplasias.
    Fakan F; Chlumská A; Krijt J; Kocová L
    Neoplasma; 1998; 45(2):102-6. PubMed ID: 9687891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver cell cytoplasmic inclusions in experimental porphyrias: their demonstration with the ferric ferricyanide reduction reaction.
    Fakan F; Chlumská A; Krijt J; Safanda J; Michal M
    Exp Toxicol Pathol; 1997 Aug; 49(3-4):289-93. PubMed ID: 9314066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test.
    Fakan F; Chlumská A
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(4):365-8. PubMed ID: 2820121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sclerodermatous changes in porphyria cutanea tarda: six cases].
    Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F
    Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis].
    Moreno FJ; Santoyo J; Bondía JA; Suárez MA; Jiménez M; Fernández JL; Conde M; Marín R; Ribeiro M; Peláez JM; de la Fuente A
    Rev Esp Enferm Dig; 1998 Jan; 90(1):48-50. PubMed ID: 9558946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron and porphyria cutanea tarda.
    D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatic porphyria and hepatitis B and C virus infections].
    Malina L; Stránský J; Havlícková M; Zd'árský E
    Cas Lek Cesk; 1998 Sep; 137(18):561-4. PubMed ID: 9818466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda in a Swedish population: risk factors and complications.
    Rossmann-Ringdahl I; Olsson R
    Acta Derm Venereol; 2005; 85(4):337-41. PubMed ID: 16191856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver cirrhosis and chronic hepatic porphyria].
    Pätzold K; Hahn L; Lohmann J; Porst H
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():114-5. PubMed ID: 7483690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scleroderma and porphyria cutanea tarda].
    Tsukazaki N; Okada S; Yoshida H
    Nihon Rinsho; 1995 Jun; 53(6):1463-7. PubMed ID: 7616663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection with hepatitis C virus in porphyria cutanea tarda].
    Lima J; Serejo F; Gloria H; Ramalho F; Moura MC
    Acta Med Port; 1996; 9(7-9):283-6. PubMed ID: 9005712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Porphyria cutanea tarda and hepatitis C virus infection].
    Held E; Petersen CS
    Ugeskr Laeger; 1997 Feb; 159(9):1284-6. PubMed ID: 9072876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Porphyria cutanea tarda].
    Bygum A; Brandrup F; Christiansen L; Petersen NE
    Ugeskr Laeger; 2000 Apr; 162(14):2020-4. PubMed ID: 10815515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
    Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
    Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus].
    Wolff C; Stella AM; Armas R; Parraguez A; Silva H; Batlle AM
    Rev Med Chil; 1998 Mar; 126(3):245-50. PubMed ID: 9674292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.